Copeland Biosciences Corp. Retains KCSA Strategic Communications as Corporate Communications Counsel
(WorldNews Canada)

TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- Copeland Biosciences Corp, a cannabis pharma company that provides safe and effective remedies to relieve inflammatory pain with propriety formulations in conjunction with modern technology and innovative delivery methods, announced today that they have retained KCSA Strategic Communications (KSCA) to implement the Company´s international investor and public relations programs. ......